NCT06651970 2026-04-15
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
AstraZeneca
Phase 4 Recruiting
AstraZeneca
Yonsei University
Amager Hospital
University Health Network, Toronto
University Hospital, Caen